Newsfeeds - Spark Newswire

1 minute read

HC Wainwright & Co. Downgrades Flexion Therapeutics to Neutral, Lowers Price Target to $10

Today, 6:05 AM

HC Wainwright & Co. analyst Patrick Trucchio downgrades Flexion Therapeutics (NASDAQ:FLXN) from Buy to Neutral and lowers the price target from $25 to $10.

FLXN

1 minute read

Analyst Ratings

Analyst Ratings For Flexion Therapeutics

By Benzinga Insights

Today, 6:05 AM

Over the past 3 months, 4 analysts have published their opinion on Flexion Therapeutics (NASDAQ:FLXN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

FLXN

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 12, 2021

By Benzinga Insights

Today, 6:05 AM

Upgrades

ABNB

6 minute read

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

By Shanthi Rexaline

Today, 6:05 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11)

ABSI

1 minute read

BMO Capital Downgrades Flexion Therapeutics to Market Perform, Lowers Price Target to $12

By Benzinga Newsdesk

Today, 6:05 AM

BMO Capital analyst Gary Nachman downgrades Flexion Therapeutics (NASDAQ:FLXN) from Outperform to Market Perform and lowers the price target from $20 to $12.

FLXN

1 minute read

Raymond James Downgrades Flexion Therapeutics to Market Perform

By Benzinga Newsdesk

Today, 6:05 AM

Raymond James analyst Elliot Wilbur downgrades Flexion Therapeutics (NASDAQ:FLXN) from Strong Buy to Market Perform.

FLXN

3 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:05 AM

Gainers

ACY

2 minute read

Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher

By Lisa Levin

Today, 6:05 AM

Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P also fell, dropping 0.26% to 4,379.88.

ADMS

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 6:05 AM

ADMS

2 minute read

Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals

By Lisa Levin

Today, 6:05 AM

Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also rose, gaining 0.44% to 4,410.73.

ADMS